at this point in time, don’t begrudge the shorters too much....

at this point in time, don’t begrudge the shorters too much. They are simply providing some further opportunities to buy. Sure it would be nice to be 1.60 + per share but we know the announcements due. Their betting the price drops whilst we wait for announcements, but that is a huge risk to take.

Potentially the suspicious buyer the day before the Mundi pharma deal is taking some profits as well. If so, this is a bigger concern and should be looked at by ASIC to see if there was insider trading. Pure speculation on my part, but it seems too convenient..

The story remains the same as a few days ago, fda submission done and regional deals are falling into place. Contracts are being reviewed and vivagel / flurostat is about to hit the shelves in Australia. Oh, and the dep trials are enrolling patients in the UK whilst we also have the Astrazeneca partnership progressing. We have 50 mil in the bank which is more than enough to see out any short term negative price action.

Many have pointed out the probable drain on resources and management focus due to the FDA submission. Now this is complete we should see deals done quickly.